How to identify & manage risks in clinical trial supplies & comparator sourcing

Webinar: How to identify and manage risks in clinical trial supplies and comparator sourcing

CSI hosted a webinar with Xtalks on Monday, November 16, 2020, on How to identify and manage risks in clinical trial supplies and comparator sourcing.

If you joined us for the webinar, we hope you had a great experience with us and took some new learnings from our discussion.

The webinar, hosted by Vanessa Dekou and Kotaro Yoshizawa, discussed the risks involved in clinical trial supplies and comparator sourcing and how you can manage these risks to ensure a successful clinical trial on a global scale.

The webinar covered:

If you missed the webinar or would like to watch it again, follow this link to access the webinar.

MORE INSIGHTS

The advantages of biosimilars vs branded products in clinical trials

The advantages of biosimilars vs branded products in clinical trials

The role of biosimilars in clinical trials and key regulatory considerations

The growth in the biosimilar market since 2006 has been significant.